Literature DB >> 34171512

Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.

Yohei Saito1, Yukako Taniguchi1, Sachika Hirazawa1, Yuta Miura1, Hiroyuki Tsurimoto1, Tomoki Nakayoshi2, Akifumi Oda2, Ernest Hamel3, Katsumi Yamashita1, Masuo Goto4, Kyoko Nakagawa-Goto5.   

Abstract

A new biological scaffold was produced by replacing the 6π-electron phenyl ring-B of a natural flavone skeleton with a 10π-electron benzothiophene (BT). Since aromatic rings are important for ligand protein interactions, this expansion of the π-electron system of ring-B might change the bioactivity profile. One of the resulting novel natural product-inspired compounds, 2-(benzo[b]thiophen-3-yl)-5-hydroxy-7-isopropoxy-6-methoxyflavone (6), effectively arrested the cell cycle at the G2/M phase and displayed significant antiproliferative effects with IC50 values of 0.05-0.08 μM against multiple human tumor cell lines, including a multidrug resistant line. A structure-activity relationship study revealed that a 10π-electron system with high aromaticity, juxtaposed 4-oxo and 5-hydroxy groups, and 7-alkoxy groups were important for potent antimitotic activity. Interestingly, two BT-flavonols (3-hydroxyflavone), 16 and 20, with 3-hydroxy and 5-alkoxy groups, induced distinct biological profiles affecting the cell cycle at the G1/S phase by inhibition of DNA replication through an interaction with topoisomerase I.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Antiproliferative activity; Benzothiophene; Flavone; Flavonol; Topoisomerase I; Tubulin

Year:  2021        PMID: 34171512     DOI: 10.1016/j.ejmech.2021.113578

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors.

Authors:  Yaqing Zuo; Rongrong Li; Yan Zhang; Guochen Bao; Yi Le; Longjia Yan
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.